Mon, December 6, 2021
Sat, December 4, 2021
Fri, December 3, 2021
Thu, December 2, 2021
Wed, December 1, 2021
Tue, November 30, 2021
Mon, November 29, 2021
Fri, November 26, 2021
Wed, November 24, 2021
Tue, November 23, 2021

Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $200 on, Nov 30th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-200-on-nov-30th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Increased Target from $135 to $200 on, Nov 30th, 2021.

Patrick has made no other calls on VIR in the last 4 months.



There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $37 on, Monday, October 25th, 2021
  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021


This is the rating of the analyst that currently disagrees with Patrick


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021

Publication Contributing Sources